Check the label for the full ingredient list
(PubMed) Villamor E, Rifas-Shiman SL, Gillman MW, Oken E
A healthy and balanced gut is home to a diverse community of beneficial microorganisms that work together to support overall gastrointestinal health
Tirzepatide: Dual Agonist Therapy Explained Tirzepatide activates both GIP and GLP-1 receptors, two incretin pathways that regulate insulin release, appetite, and metabolic signaling
What matters is the clinical outcome, and head-to-head data suggests Mounjaro's dual-receptor approach generally produces greater average weight loss than GLP-1-only medications
Finally, our study focused on the role of the PPAR/--catenin-TCF-4 pathway, but other potential pathways and interactions may also play a role and warrant further investigation